A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2002
10/03/2002	WO2002076604A1 Microcapsules (viii)
10/03/2002	WO2002076603A1 Nanocapsules
10/03/2002	WO2002076602A1 Microcapsules (vii)
10/03/2002	WO2002076514A2 Use of solid particles for thermally extracting perfume oils and/or aromas
10/03/2002	WO2002076509A2 Preparation for the prophylaxis of restenosis
10/03/2002	WO2002076506A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
10/03/2002	WO2002076502A1 Human medical treatment by application of immunoglobulin a
10/03/2002	WO2002076499A2 Combination treatment of pancreatic cancer
10/03/2002	WO2002076495A1 Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability
10/03/2002	WO2002076491A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002	WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses
10/03/2002	WO2002076474A1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
10/03/2002	WO2002076469A1 A novel technology of intracellular delivery of dna oligonucleotides to improve drug activity
10/03/2002	WO2002076454A1 Method for treatment of cancer and compositions for use therein
10/03/2002	WO2002076452A1 Use of melationin in the manufacture of a medicament for treating attention deficit hyperactive disorder
10/03/2002	WO2002076446A1 Esmolol formulation
10/03/2002	WO2002076441A1 Microemulsions as precursors to solid nanoparticles
10/03/2002	WO2002076433A1 Dental formulation
10/03/2002	WO2002076432A2 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
10/03/2002	WO2002076431A1 Biodegradable triblock copolymers as drug solubilizing agents
10/03/2002	WO2002076430A1 Carbon nanotubes in structures and repair compositions
10/03/2002	WO2002076429A1 Ph-dependent sustained release, drug, delivery composition
10/03/2002	WO2002076428A1 Liposome composition for improved intracellular delivery of a therapeutic agent
10/03/2002	WO2002076427A2 Ph sensitive liposomal drug delivery
10/03/2002	WO2002076426A2 Intravaginal drug delivery devices for the administration of an antimicrobial agent
10/03/2002	WO2002076425A2 Manufacturing dissolvable dosage forms
10/03/2002	WO2002076424A1 Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles
10/03/2002	WO2002076411A2 Dermatological agent for the treatment of skin trauma, especially in burn conditions
10/03/2002	WO2002076398A2 Improved forms of pharmaceutically active agents and method for manufacture thereof
10/03/2002	WO2002076392A2 Thermally reversible water in oil in water emulsions
10/03/2002	WO2002076390A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
10/03/2002	WO2002076379A2 Medicated tattoos
10/03/2002	WO2002076376A2 A stable pharmaceutical composition of pravastatin
10/03/2002	WO2002076344A1 Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
10/03/2002	WO2002076242A1 Nutritional supplement to treat macular degeneration
10/03/2002	WO2002076229A1 One-step process for preparing chewing gum
10/03/2002	WO2002076211A1 Nicotine-containing oral dosage form
10/03/2002	WO2002065834A3 Novel formulations of carvedilol
10/03/2002	WO2002057424A3 Nucleic acid delivery formulations
10/03/2002	WO2002051436A3 Stable enzymatic wound debrider
10/03/2002	WO2002044232A8 Polyanhydrides
10/03/2002	WO2002044206A3 Membrane fusion proteins derived from reovirus
10/03/2002	WO2002017921A3 Paroxetine compositions and processes for making the same
10/03/2002	WO2002013783A8 Process for preparing polymer-based sustained release compositions
10/03/2002	WO2002012188A3 Indole compounds useful for the treatment of cancer
10/03/2002	WO2001093836A3 Encapsulation of polynucleotides and drugs into targeted liposomes
10/03/2002	WO2001064187A8 Anaesthetic formulations
10/03/2002	WO2001017508A9 Cationic liposome delivery of taxanes to angiogenic blood vessels
10/03/2002	WO2001003648A9 Oregano-based therapeutic composition
10/03/2002	US20020143408 Prosthetic foot with tunable performance
10/03/2002	US20020143406 Prosthetic foot with tunable performance
10/03/2002	US20020143348 Embolic devices capable of in-situ reinforcement
10/03/2002	US20020143310 Method of producing an absorbent foam material
10/03/2002	US20020143072 Low turbidity microemulsions
10/03/2002	US20020143065 Useful for the delivery of the (+) tramadol enantiomer and the (-) tramadol enantiomer
10/03/2002	US20020143062 Admixing retinoid or a derivative with dimyristoyl phosphatidylcholine, soybean oil, tertiarybutyl alcohol and water to produce mixture
10/03/2002	US20020143058 Blending ingredients including a hygroscopic salt of valproic acid, carbomer, and non-hygroscopic additive to form non-hygroscopic stable oral pharmaceutical formulation
10/03/2002	US20020143051 Shelf-life
10/03/2002	US20020143050 Premixed amiodarone parenteral solution and method for making the same
10/03/2002	US20020143048 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
10/03/2002	US20020143046 Used as calcium channel blockers
10/03/2002	US20020143038 Parenteral formulation for epothilone analogs
10/03/2002	US20020143028 For therapy of pain
10/03/2002	US20020143016 Administering to a patient suffering from anxiety a therapeutically or prophylactically effective amount of N-desmethylzopiclone, or a pharmaceutically acceptable salt, solvate, hydrate, or clathrate
10/03/2002	US20020142999 Topical ophthalmic, otic or nasal drug for therapy of bacterial infections
10/03/2002	US20020142997 Liquid pharmaceutical composition for treating bone diseases
10/03/2002	US20020142972 Antiparasitic formulation
10/03/2002	US20020142944 Treatment of ocular disorders
10/03/2002	US20020142941 Intraductal treatment targeting methylated promoters in breast cancer
10/03/2002	US20020142389 Soluble T cell receptor
10/03/2002	US20020142368 Gelatin manufacturing process and product
10/03/2002	US20020142093 Emulsion-based processes for making microparticles
10/03/2002	US20020142051 Hydrogen peroxide disinfectant with increased activity
10/03/2002	US20020142050 Dissolving water insoluble drug in volatility solvent
10/03/2002	US20020142049 Precipitating drug as solid
10/03/2002	US20020142048 Injectable pharmaceutical composition comprising coated particles of camptothecin
10/03/2002	US20020142047 Microsphere delivery of mucin peptides
10/03/2002	US20020142046 Protein particles for therapeutic and diagnostic use
10/03/2002	US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002	US20020142044 Pharmaceutical dosage forms with enhanced cohesive and compressiblity properties
10/03/2002	US20020142043 Powder containing fat-soluble drug
10/03/2002	US20020142042 pH-sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
10/03/2002	US20020142041 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition
10/03/2002	US20020142040 Antibacterial composition for topical administration containing antibiotic
10/03/2002	US20020142039 Sustained drug release
10/03/2002	US20020142038 Rapid disintegration; taste
10/03/2002	US20020142037 Process for the manufacture of a pharmaceutical composition with modified release of active principle comprising a matrix
10/03/2002	US20020142036 Active substance-containing multi-layer film of hydrophilic polymers crosslinked in situ
10/03/2002	US20020142035 Metering and packaging of controlled release medication
10/03/2002	US20020142034 Orally disintegrable tablets
10/03/2002	US20020142033 Administering an anticholinergic agent; side effect reduction
10/03/2002	US20020142032 Mixture of microcrystalline cellulose and silica
10/03/2002	US20020142031 Highly flexible starch-based films
10/03/2002	US20020142030 Administering by mouth freeze dried liposome absorbed with antigen; antiinflammatroy agents
10/03/2002	US20020142029 Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments
10/03/2002	US20020142028 Hormone replacement therapy method
10/03/2002	US20020142022 Microtubes; for pesticides
10/03/2002	US20020142018 Mixture of alcohol and water; presurgery scrub
10/03/2002	US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002	US20020141970 Stabilized with chelate compound; storage stability

1 ... 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 ... 2991